Fmr Llc ownership in HVE / Innoviva, Inc.

Innoviva, Inc.

DE ˙ DB ˙ US45781M1018

19,20 € ↑0,70 (3,78%)

2026-06-04
AKTIENPREIS

Security	DE:HVE / Innoviva, Inc.
Institution	Fmr Llc
Latest Disclosed Ownership	1,194 shares
Ownership	0.00%

2023-08-10 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,194 shares of Innoviva, Inc. (DE:HVE). This represents 0.002 percent ownership of the company. In their previous filing dated 2023-02-09 , Fmr Llc had reported owning 2,498,355 shares, indicating a decrease of -99.95 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2023-08-10	2023-08-10	13G/A	2,498,355	1,194	-99.95	0.00	-99.97
2023-02-09	2023-02-09	13G/A	3,192,663	2,498,355	-21.75	6.45	-21.74
2022-12-12	2022-12-12	13G/A	5,448,669	3,192,663	-41.40	8.25	-41.43
2022-02-09	2022-02-09	13G/A	3,953,716	5,448,669	37.81	14.08	33.64
2021-11-10	2021-11-10	13G		3,953,716		10.53
2018-08-10	2018-08-10	13G/A	7,364,597	1,425,843	-80.64	1.40	-80.72
2018-05-10	2018-05-10	13G/A	13,794,465	7,364,597	-46.61	7.28	-42.98
2018-02-13	2018-02-13	13G/A	14,786,530	13,794,465	-6.71	12.77	-6.10
2017-02-14	2017-02-14	13G/A	17,613,872	14,786,530	-16.05	13.60	-9.33
2017-02-14	2017-02-14	13G/A
2016-02-12	2016-02-12	13G/A	17,569,014	17,613,872	-100.00	15.00
2015-02-13	2015-02-13	13G/A		17,087,423		14.81
2014-02-14	2014-02-14	13G/A		12,053,867		10.78
2013-02-14	2013-02-14	13G/A		13,788,285		14.09
2012-02-14	2012-02-14	13G/A		11,053,167		12.98

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	INNOVIVA	COM	45781M101	68,730	39,698	136.74	1,601	176.03	0.0000
2026-02-17	2025-12-31	13F	INNOVIVA	COM	45781M101	29,032	-8,280	-22.19	580	-14.71	0.0000
2025-11-13	2025-09-30	13F	INNOVIVA	COM	45781M101	37,312	2,609	7.52	681	-2.44	0.0000
2025-08-14	2025-06-30	13F	INNOVIVA	COM	45781M101	34,703	21,507	162.98	697	191.63	0.0000
2025-05-12	2025-03-31	13F	INNOVIVA	COM	45781M101	13,196	-31,427	-70.43	239	-69.12	0.0000
2025-02-13	2024-12-31	13F	INNOVIVA	COM	45781M101	44,623	34,504	340.98	774	296.92	0.0000
2024-11-13	2024-09-30	13F	INNOVIVA	COM	45781M101	10,119	771	8.25	195	27.45	0.0000
2024-08-13	2024-06-30	13F	INNOVIVA	COM	45781M101	9,348	748	8.70	153	16.79	0.0000
2024-05-13	2024-03-31	13F	INNOVIVA	COM	45781M101	8,600	6,647	340.35	131	1,771.43	0.0000
2024-02-13	2023-12-31	13F	THESEUS PHARMACEUTICALS	COM	88369M101	1,953	1,198	158.68	8	250.00	0.0000
2024-02-13	2023-12-31	13F	INNOVIVA	COM	45781M101	7,419	613		119		0.0000
2023-11-13	2023-09-30	13F	THESEUS PHARMACEUTICALS	COM	88369M101	755	-804,886	-99.91	2	-99.97	0.0000
2023-11-13	2023-09-30	13F	INNOVIVA	COM	45781M101	6,806	-199		88		0.0000
2023-08-11	2023-06-30	13F	THESEUS PHARMACEUTICALS	COM	88369M101	805,641	-308,021	-27.66	7,517	-24.00	0.0006
2023-08-11	2023-06-30	13F	INNOVIVA	COM	45781M101	7,005	1,563		89		0.0000
2023-08-11	2023-03-31	13F/A-1	THESEUS PHARMACEUTICALS	COM	88369M101	1,113,662	-1,384,693	-55.42	9,889	-20.51	0.0009
2023-08-11	2023-03-31	13F/A-1	INNOVIVA	COM	45781M101	5,442	2,341		61		0.0000
2023-05-11	2023-03-31	13F	THESEUS PHARMACEUTICALS	COM	88369M101	1,113,662	-1,384,693		9,889		0.0009
2023-05-11	2023-03-31	13F	INNOVIVA	COM	45781M101	5,442	2,341		61		0.0000
2023-02-13	2022-12-31	13F	THESEUS PHARMACEUTICALS	COM	88369M101	2,498,355	-2,304,885	-47.99	12,442	-55.34	0.0012
2023-02-13	2022-12-31	13F	INNOVIVA	COM	45781M101	3,101	52		41		0.0000
2022-11-10	2022-09-30	13F	THESEUS PHARMACEUTICALS	COM	88369M101	4,803,240	-380,123	-7.33	27,859	-2.81	0.0029
2022-11-10	2022-09-30	13F	INNOVIVA	COM	45781M101	3,049	251		36		0.0000
2022-08-12	2022-06-30	13F	THESEUS PHARMACEUTICALS	COM	88369M101	5,183,363	-374,084	-6.73	28,664	-55.27	0.0029
2022-08-12	2022-06-30	13F	INNOVIVA	COM	45781M101	2,798	-290		41		0.0000
2022-05-13	2022-03-31	13F	THESEUS PHARMACEUTICALS	COM	88369M101	5,557,447	108,778	2.00	64,077	-7.25	0.0051
2022-05-13	2022-03-31	13F	INNOVIVA	COM	45781M101	3,088	2,157		60		0.0000
2022-02-14	2021-12-31	13F	THESEUS PHARMACEUTICALS	COM	88369M101	5,448,669	5,447,737	584,521.14	69,089	431,706.25	0.0051
2022-02-14	2021-12-31	13F	INNOVIVA	COM	45781M101	931	-1		16		0.0000
2022-02-14	2021-09-30	13F/A-1	INNOVIVA	COM	45781M101	932	407	77.52	16	128.57	0.0000
2021-11-15	2021-09-30	13F	INNOVIVA	COM	45781M101	932	407		16		0.0000
2021-08-13	2021-06-30	13F	INNOVIVA	COM	45781M101	525	75	16.67	7	40.00	0.0000
2021-05-14	2021-03-31	13F	INNOVIVA	COM	45781M101	450	0	0.00	5	-16.67	0.0000
2021-02-08	2020-12-31	13F	INNOVIVA	COM	45781M101	450	0	0.00	6	20.00	0.0000
2020-11-13	2020-09-30	13F	INNOVIVA	COM	45781M101	450	0	0.00	5	-16.67	0.0000
2020-08-24	2020-06-30	13F/A-1	INNOVIVA	COM	45781M101	450	0	0.00	6	20.00	0.0000
2020-08-13	2020-06-30	13F	INNOVIVA	COM	45781M101	450	0		6		0.1474
2020-05-14	2020-03-31	13F	INNOVIVA	COM	45781M101	450	0	0.00	5	-16.67	0.0000
2020-02-07	2019-12-31	13F	INNOVIVA	COM	45781M101	450	-1,750	-79.55	6	-73.91	0.0000
2019-11-13	2019-09-30	13F	INNOVIVA	COM	45781M101	2,200	1,721	359.29	23	228.57	0.0000
2019-08-13	2019-06-30	13F	INNOVIVA	COM	45781M101	479	29	6.44	7	16.67	0.0000
2019-05-13	2019-03-31	13F	INNOVIVA	COM	45781M101	450	0	0.00	6	-25.00	0.0000
2019-02-13	2018-12-31	13F	INNOVIVA	COM	45781M101	450	0	0.00	8	14.29	0.0000
2018-11-09	2018-09-30	13F	INNOVIVA	COM	45781M101	450	-2,686,843	-99.98	7	-99.98	0.0000
2018-08-10	2018-06-30	13F	INNOVIVA	COM	45781M101	2,687,293	-6,073,058	-69.32	37,085	-74.61	0.0044
2018-05-14	2018-03-31	13F	INNOVIVA	COM	45781M101	8,760,351	-5,031,585	-36.48	146,035	-25.38	0.0173
2018-02-12	2017-12-31	13F	INNOVIVA	COM	45781M101	13,791,936	-2,230,544	-13.92	195,708	-13.49	0.0229
2017-11-13	2017-09-30	13F	INNOVIVA	COM	45781M101	16,022,480	5,224	0.03	226,237	10.35	0.0274
2017-08-29	2017-06-30	13F/A-1	INNOVIVA	COM	45781M101	16,017,256	802,605	5.28	205,021	-2.57	0.0255
2017-08-11	2017-06-30	13F	INNOVIVA	COM	45781M101	16,017,256	802,605		205,021
2017-05-11	2017-03-31	13F	INNOVIVA	COM	45781M101	15,214,651	428,295	2.90	210,419	33.00	0.0267
2017-02-10	2016-12-31	13F	INNOVIVA	COM	45781M101	14,786,356	-766,013	-4.93	158,214	-7.43	0.0211
2016-11-14	2016-09-30	13F	INNOVIVA	COM	45781M101	15,552,369	-1,525,403	-8.93	170,921	-4.95	0.0228
2016-08-11	2016-06-30	13F	INNOVIVA	COM	45781M101	17,077,772	-60,216	-0.35	179,829	-16.66	0.0245
2016-05-16	2016-03-31	13F	INNOVIVA	COM	45781M101	17,137,988	-475,884	-2.70	215,767	16.22	0.0299
2016-02-12	2015-12-31	13F	THERAVANCE	COM	88338T104	17,613,872	44,858	0.26	185,650	47.17	0.0250
2015-11-10	2015-09-30	13F	THERAVANCE	COM	88338T104	17,569,014	38,105	0.22	126,146	-60.18	0.0180
2015-08-25	2015-06-30	13F/A-1	THERAVANCE	COM	88338T104	17,530,909	29,289	0.17	316,783	15.14	0.0406
2015-08-13	2015-06-30	13F	THERAVANCE	COM	88338T104	17,530,909			316,783
2015-05-14	2015-03-31	13F	THERAVANCE	COM	88338T104	17,501,620	414,197	2.42	275,125	13.79	0.0350
2015-02-17	2014-12-31	13F	THERAVANCE	COM	88338T104	17,087,423	2,103,759	14.04	241,787	-5.58	0.0315
2014-11-14	2014-09-30	13F	THERAVANCE	COM	88338T104	14,983,664	3,211,107	27.28	256,071	-26.96	0.0347
2014-08-14	2014-06-30	13F	THERAVANCE	COM	88338T104	11,772,557	1,712,741	17.03	350,587	12.64	0.0470
2014-05-15	2014-03-31	13F	THERAVANCE	COM	88338T104	10,059,816	-740,000	-6.85	311,250	-19.16	0.0432
2014-02-13	2013-12-31	13F	THERAVANCE	COM	88338T104	10,799,816	-1,127,471	-9.45	385,013	-21.06	0.0544
2013-11-14	2013-09-30	13F	THERAVANCE	COM	88338T104	11,927,287	731,828	6.54	487,707	13.06	0.0747
2013-09-24	2013-06-30	13F/A-1	THERAVANCE	COM	88338T104	11,195,459	11,195,459		431,361		0.0706
2013-08-14	2013-06-30	13F	THERAVANCE	COM	88338T104	11,195,459			431,361		0.0706

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.